As per reports, The indigenous COVID-19 vaccine, covaxin, is set to be launched on August 15, Independence day of India. A dozen institutes have been selected for clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine), the government’s top medical research body has said.
The Indian Council of Medical Research had fast-tracked the effort to develop with collaboration with Bharat Biotech International Limited.
“The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine,” the ICMR said in a letter to the institutes.
As per the latest development, the Drug Controller General of India has given approval for human trials.
Among the seven Indian firms working on developing a vaccine for coronavirus, Bharat Biotech International Limited was the first to get the regulatory nod to begin phase 1 and phase 2 human trials.
A lot of COVID-19 vaccines have been found but none of them were approved for commercial use and when the reports of the covaxin launching on August 15 started doing rounds, it created quite a buzz but nothing has been confirmed by the top officials.
Things you may want to know about the vaccine:
– Covaxin has been approved by the drug controller for human testing.
-The trials may begin from mid-July.
-Indian Council of Medical Research and National Institute of Virology are in partnership with Bharat Biotech International Limited to develop the vaccine. -It was revealed through ICMR that the vaccine can be launched on August 15, 2020
To know more about the India News: